Bortezomib and Platelet count decreased - from FDA reports


Platelet count decreased is found among people who take Bortezomib, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Dexamethasone, and have Multiple myeloma. This review analyzes which people have Platelet count decreased with Bortezomib. It is created by eHealthMe based on reports of 6,911 people who have side effects when taking Bortezomib from FDA , and is updated regularly.


Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.



On Apr, 04, 2018

6,911 people reported to have side effects when taking Bortezomib.
Among them, 757 people (10.95%) have Platelet count decreased


Number of reports submitted per year:

Could Bortezomib cause Platelet count decreased?

Time on Bortezomib when people have Platelet count decreased *:

  • < 1 month: 61.01 %
  • 1 - 6 months: 30.19 %
  • 6 - 12 months: 3.77 %
  • 1 - 2 years: 1.26 %
  • 2 - 5 years: 2.52 %
  • 5 - 10 years: 1.26 %
  • 10+ years: 0.0 %

Gender of people who have Platelet count decreased when taking Bortezomib *:

  • female: 38.16 %
  • male: 61.84 %

Age of people who have Platelet count decreased when taking Bortezomib *:

  • 0-1: 0.41000000000000003 %
  • 2-9: 0.21 %
  • 10-19: 0.62 %
  • 20-29: 1.24 %
  • 30-39: 5.59 %
  • 40-49: 6.42 %
  • 50-59: 17.39 %
  • 60+: 68.12 %

Top conditions involved for these people *:

  • Multiple Myeloma (cancer of the plasma cells): 516 people, 68.16%
  • Preventive Health Care: 67 people, 8.85%
  • Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 42 people, 5.55%
  • Plasmablastic Lymphoma (aggressive b-cell cancer occurring mainly in the jaws and oral cavity): 33 people, 4.36%
  • Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 25 people, 3.30%

Top co-used drugs for these people *:

  • Dexamethasone: 160 people, 21.14%
  • Revlimid: 153 people, 20.21%
  • Melphalan: 78 people, 10.30%
  • Cyclophosphamide: 65 people, 8.59%
  • Prednisone: 51 people, 6.74%

Top other side effects for these people *:

  • Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 284 people, 37.52%
  • Anaemia (lack of blood): 254 people, 33.55%
  • Diarrhea: 191 people, 25.23%
  • Neuropathy Peripheral (surface nerve damage): 184 people, 24.31%
  • Fatigue (feeling of tiredness): 175 people, 23.12%

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.


Want to find out more about the FDA reports used in the study? You can request them from FDA.

Do you take Bortezomib and have Platelet count decreased?

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.



Related studies

Bortezomib

Bortezomib has active ingredients of bortezomib. (latest outcomes from Bortezomib 6,914 users)

Platelet count decreased

Platelet count decreased has been reported by people with multiple myeloma, hepatitis c, preventive health care, high blood pressure, rheumatoid arthritis (latest reports from 144,869 Platelet count decreased patients).


Drugs that are associated with Platelet count decreased
Platelet count decreased (3,280 drugs)
Could your condition cause Platelet count decreased
Platelet count decreased (3,690 conditions)
Expand the study to include all drugs with the same ingredients
Platelet count decreased and drugs with ingredients of bortezomib. (4,131 reports)
Expand the study to include reports from both FDA and eHealthMe
Platelet count decreased and Bortezomib from FDA and eHealthMe reports
Bortezomib side effects
Browse all side effects of Bortezomib
a b c d e f g h i j k l m n o p q r s t u v w x y z

Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

What would happen?

Predict new side effects and undetected conditions when you take Bortezomib and have Platelet count decreased


You are not alone. Join our personalized support groups:


Can you answer these questions

More questions for: Bortezomib, Platelet count decreased

You may be interested in these posts

More posts for: Bortezomib, Platelet count decreased

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.